Italy's Genenta Science falls in Nasdaq debut

Genenta Science SpA

15/12/2021 17:49

** American depositary shares (ADS) of Genenta Science S.p.A
 GNTA.O  dipped 12.6% below their initial public offering (IPO)
price in their market debut on Wednesday 
    ** GNTA opened at $10.05; co's IPO was priced at $11.5
    ** GNTA sold 2.4 million ADSs in an upsized IPO, raising
about $27.6 million 
    ** Co also sold 720,114 ordinary shares to existing
shareholders, taking gross proceeds to about $36 million 
    ** Each ADS represents one ordinary share 
    ** The Italian biotech co is focused on the development of a
stem cell gene therapy for the treatment of solid tumor cancers 
    ** Roth Capital Partners was the sole book-running manager
of the IPO
    

 (Reporting by Sohini Podder in Bengaluru)
 ((sohini.podder@thomsonreuters.com))